Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04215510 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase: Not applicable to Phase 3v3 Show 10 more changesShow less
    • Enrollment target: 78 to 286
    • Primary completion date: Feb 1, 2024 to Mar 1, 2027
    • Start date: Apr 1, 2020 to Mar 1, 2021
    • Primary endpoint revised
    • Study sites: 0 to 3
    • Study completion date: Aug 1, 2024 to Mar 1, 2027
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: 2 to 5
    • Study description shortened, about 47 words
    • Study title expanded, about 1 word
  2. Start date: Feb 1, 2020 to Apr 1, 2020
    • Study description shortened, about 1 word
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a multicenter RCT to compare 3-year overall survival(OS) rate, progression free survival(PFS),local progression free survival(LPFS),regional progression free survival(RPFS),distant metastasis free survival(DMFS), and toxicities of endonasal endoscopic surgery versus IMRT.
Trial Details
NCT Number NCT04215510
Lead Sponsor Eye & ENT Hospital of Fudan University
Collaborators: Chinese Academy of Medical Sciences, Shanghai Municipal Science and Technology Commission
Conditions
(from sponsor)		 Recurrent Nasopharyngeal Carcinoma
Related terms Nasopharyngeal Carcinoma
Enrollment 286 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov